Cargando…
Deep neural network modeling identifies biomarkers of response to immune-checkpoint therapy
Immunotherapy has shown significant promise as a treatment for cancer, such as lung cancer and melanoma. However, only 10%–30% of the patients respond to treatment with immune checkpoint blockers (ICBs), underscoring the need for biomarkers to predict response to immunotherapy. Here, we developed De...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044175/ https://www.ncbi.nlm.nih.gov/pubmed/35494249 http://dx.doi.org/10.1016/j.isci.2022.104228 |